Intracellular Stability of Anti-caspase-3 Intrabodies Determines Efficacy in Retargeting the Antigen*

Although intracellular antibodies (intrabodies) are being explored as putative therapeutic and research reagents, little is known about the principles that dictate the efficacy of these molecules. In our efforts to address this issue, we generated a panel of five intrabodies, directed against catalytically inactive murine caspase-3, by screening single-chain antibody (Fv) phage display libraries. Here we determined criteria that single-chain Fv fragments must fulfill to act as efficient intrabodies. The affinities of these intrabodies, as measured by surface plasmon resonance, varied ∼5-fold (50–250 nm). Despite their substantial sequence similarity, only two of the five intrabodies were able to significantly accumulate intracellularly. These disparities in intracellular expression levels were reflected by differences in the stability of the purified protein species when analyzed by urea denaturation studies. We observed varied efficiencies in retargeting the antigen murine caspase-3, from the cytosol to the nucleus, mediated by intrabodies tagged with an SV40 nuclear localization signal. Our results demonstrate that the intrinsic stability of the intrabody, rather than its affinity for the antigen, dictates its intracellular efficacy.

[1]  G. Salvesen,et al.  Properties of the caspases. , 1998, Biochimica et biophysica acta.

[2]  Tristan J. Vaughan,et al.  Human Antibodies with Sub-nanomolar Affinities Isolated from a Large Non-immunized Phage Display Library , 1996, Nature Biotechnology.

[3]  William D. Richardson,et al.  A short amino acid sequence able to specify nuclear location , 1984, Cell.

[4]  J. Kirsch,et al.  Role of the minor energetic determinants of chicken egg white lysozyme (HEWL) to the stability of the HEWL • antibody scFv‐10 complex , 2000, Proteins.

[5]  A. Porter,et al.  Emerging roles of caspase-3 in apoptosis , 1999, Cell Death and Differentiation.

[6]  D. Curiel,et al.  Rapid Targeted Tumor Killing via an Intracellular Antibody against erbB-2 , 2022 .

[7]  J. Boyer,et al.  Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Gerhart,et al.  Efficient construction of a large nonimmune phage antibody library: the production of high-affinity human single-chain antibodies to protein antigens. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[9]  N. Thornberry,et al.  The Caspase-3 Precursor Has a Cytosolic and Mitochondrial Distribution: Implications for Apoptotic Signaling , 1998, The Journal of cell biology.

[10]  A. Plückthun,et al.  An intrinsically stable antibody scFv fragment can tolerate the loss of both disulfide bonds and fold correctly , 1998, FEBS letters.

[11]  T. Rabbitts,et al.  Selection of antibodies for intracellular function using a two-hybrid in vivo system. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Pini,et al.  Design and Use of a Phage Display Library , 1998, The Journal of Biological Chemistry.

[13]  Pace Cn,et al.  Measuring and increasing protein stability , 1990 .

[14]  M. Luskin,et al.  The neuronal progenitor cells of the forebrain subventricular zone: intrinsic properties in vitro and following transplantation. , 1998, Methods.

[15]  H R Hoogenboom,et al.  Diverting a protein from its cellular location by intracellular antibodies. The case of p21Ras. , 2000, European journal of biochemistry.

[16]  S. Srinivasula,et al.  In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Nicoletta Berardi,et al.  Phenotypic Knockout of Nerve Growth Factor in Adult Transgenic Mice Reveals Severe Deficits in Basal Forebrain Cholinergic Neurons, Cell Death in the Spleen, and Skeletal Muscle Dystrophy , 2000, The Journal of Neuroscience.

[18]  Thomas E. Creighton,et al.  Protein structure : a practical approach , 1997 .

[19]  W. Marasco.  Intrabodies: turning the humoral immune system outside in for intracellular immunization , 1997, Gene Therapy.

[20]  K. Schulze-Osthoff,et al.  The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. , 1999, Immunity.

[21]  A. Cattaneo,et al.  Redox State of Single Chain Fv Fragments Targeted to the Endoplasmic Reticulum, Cytosol and Mitochondria , 1995, Bio/Technology.

[22]  A. Plückthun,et al.  Correlation between in Vitro Stability and in Vivo Performance of Anti-GCN4 Intrabodies as Cytoplasmic Inhibitors* , 2000, The Journal of Biological Chemistry.

[23]  D. Danley,et al.  Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7. , 1999, Journal of immunological methods.

[24]  S. Chen,et al.  Intracellular antibodies against HIV-1 envelope protein for AIDS gene therapy. , 1998, Human gene therapy.

[25]  S. Muyldermans,et al.  The regulated expression of an intrabody produces a mutant phenotype in Drosophila , 1998, FEBS letters.

[26]  H. Gilbert.  Molecular and cellular aspects of thiol-disulfide exchange. , 2006, Advances in enzymology and related areas of molecular biology.

[27]  H. Horvitz,et al.  The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. , 1996, Genes & development.